BioSpace News Archive

Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting

Bausch + Lomb Corporation today announced the presentation of eight scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in New Orleans from April 23-27, 2023.

April 20, 2023

·

6 min read

Genetown

ProQR Announces Upcoming Investor Conferences in April and May 2023

ProQR Therapeutics NV. announced that Company management will participate in the following upcoming investor conferences and events.

April 20, 2023

·

4 min read

Business

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

Collegium Pharmaceutical, Inc. announced that it will report first quarter 2023 financial results after the market closes on Thursday, May 4, 2023.

April 20, 2023

·

1 min read

PharmAla Biotech to supply Clinical Psychedelic Lab at Monash University Clinical Trial with LaNeo MDMAFourth major clinical trial to select PharmAla Biotech as supplier in Australia

PharmAla Biotech is proud to have been selected as the MDMA manufacturing partner for the Clinical Psychedelic Lab at Monash University’s upcoming Phase 2 Clinical Trial.

April 20, 2023

·

3 min read

Business

Amedisys Announces First Quarter 2023 Earnings Release and Conference Call Date

Amedisys, Inc., a leading provider of home health, hospice and high-acuity care, will report results for the first quarter ended March 31, 2023, after the market closes on May 3, 2023.

April 20, 2023

·

1 min read

Drug Development

Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today reported positive topline results from its Phase 2 ORCA-V1 trial.

April 20, 2023

·

9 min read

BioMidwest

Alimera Data to be Featured in Scientific Programming at Upcoming Annual Congress

Alimera Sciences, Inc. announced that ILUVIEN® will be highlighted in four posters to be presented at the annual Association for Research in Vision and Ophthalmology conference being held in New Orleans, Louisiana from April 23-27, 2023.

April 20, 2023

·

2 min read

Pharm Country

Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting

Ocugen, Inc. announced that the Company will present on its innovative modifier gene therapy platform at The Association for Research in Vision and Ophthalmology 2023 Annual Meeting in New Orleans from April 23-27, 2023.

April 20, 2023

·

5 min read

FDA

DEXIS Announces FDA 510(k) Clearance of pathological dental findings AI on 2D intraoral X-ray images

DEXIS announces FDA 510(k) Clearance for dental findings AI on 2D intraoral X-ray images.

April 20, 2023

·

3 min read

BioCapital

Caring Cross Co-Founder and Executive Director Boro Dropulić, Ph.D., to Participate in Economist Impact’s Inaugural Cell and Gene Therapy Summit

Caring Cross announced that Boro Dropulić, Ph.D., Co-founder and Executive Director of Caring Cross, will participate in a panel discussion at the inaugural Cell and Gene Therapy Summit on April 24-25, 2023 in Brussels.

April 20, 2023

·

3 min read